ABM Respiratory Care Receives the US FDA’s Clearance of Biwaze Clear System

Shots:

The company received 510(k) clearance for its BiWaze clear system from the US FDA for acute & chronic respiratory conditions in the hospital, home & long-term care environments, also prevent bacterial & viral infections like COVID-19
The new airway clearance system provides Oscillating lung expansion (OLE) therapy using a unique dual lumen breathing circuit to help patients clear their airways and prevent or treat atelectasis
OLE therapy was found to decrease 31% of postoperative pulmonary complications and reduce the mean length of hospital stay by 1.6 days in a recent study with post-surgical patients. The system offers 3 therapies, incl. lung expansion, high-frequency oscillation, nebulization & Aerogen Solo

Ref: PR Newswire | Image: ABM Respiratory Care

Related News: SeaStar Medical Signed US License and Distribution Agreement with Nuwellis for Selective Cytopheretic Device to Treat Acute Kidney Injury in Pediatric Patients